Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (182)

Latest Posts

About This Stock More About This Stock
DOW + (8 S&P 500 Top Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes
Sunday, January 12, 2020 9:43 PM EST
The cumulative 2020 earnings power of these 38 stocks was revised down by -1.97% in the past 60 days [A significant portion of this downward revision is related to BA (short term markdown in EPS) – which will fully recover its earnings power 2021].
In this article: ATVXRVZSCOCATVXRVZSCO, ABT, AXP, BA, BAC, C, CAT, CVX, DIS, DOW, GS, HD, IBM, JNJ, JPM, KO, MA, MCD, MMM, MRK, NKE, PEP, PFE, PG, T, TRV, UNH, UTX, V, VZ, WFC, WMT, XOM, AAPL, CSCO, INTC, MSFT, WBA, DIA, SPY
Read
3 Dividend-Paying Large Cap Pharma Stocks To Consider For 2020
Article By: Zacks Investment Research
Friday, December 27, 2019 5:37 PM EST
The strong end to the year has helped lift the S&P 500 over 28% in 2019. But investors now wonder what might be in store for equities in the upcoming year.
In this article: JNJ, MRK, ABBV Also: ABT, AGN, AMZN
Read
JNJ Bullish Outlook Suggests Further Upside For Next Year
Article By: Elliottwave Forecast
Friday, December 27, 2019 12:02 PM EST
JNJ saw a sideways consolidation in the recent 2 years within a Bullish Triangle and the stock is currently in the process of breaking out of that range.
In this article: JNJ
Read
E Healthcare Sector ETF Poised To End Nine-Week Bullish Streak
Article By: Jignesh Davda
Saturday, December 21, 2019 11:48 AM EST
Three top healthcare stocks in XLV are showing signs that they could retreat from current levels, which could be setting up a buying opportunity.
In this article: JNJ, UNH, MRK, XLV
Read
Morgan Stanley Sees 'Defensiveness Returning' At J&J, Upgrades To Overweight
Article By: The Fly
Tuesday, December 17, 2019 8:48 AM EST
Morgan Stanley analyst David Lewis upgraded Johnson & Johnson to Overweight from Equal Weight with a price target of $170, up from $145.
In this article: JNJ
Read

PARTNER HEADLINES

Latest Tweets for $JNJ

No tweets yet!

$JNJ

How To Invest In Woman-Led Companies With ETFs & Stocks
Financial Zonked Talk 4/9/2019 4:45:28 AM

Not until they remove cancer causing $JNJ from portfolio.

Johnson & Johnson: Recession Safety, Growth And Valuation
Stuart Saunders 10/1/2018 2:44:49 AM

Inventors, do not trust johnson and Johnson $JNJ

Johnson & Johnson Upgraded To Neutral From Sell At Goldman Sachs
Bill Myers 7/12/2018 12:37:26 PM

Still not impressed with $JNJ.

1 to 3 of 3 comments